Rutkove Receives $1m Prize For Discovery
Seward Rutkove, MD, Chief of the Division of Neuromuscular Disease at Beth Israel Deaconess Medical Center, has been awarded Prize4Life's ALS Biomarker Challenge for the discovery of a method that could facilitate rapid development of treatments for Amyotrophic Lateral Sclerosis, commonly known as Lou Gehrig's disease.
The $1 million award results for the 2006 challenge issued by the non-profit organization dedicated to accelerating the discovery of a cure for ALS by offering incentives to drive innovation. That challenge was to find a better method for assessing the rate of progression of ALS such that the cost of Phase II clinical trials could be cut in half.
For more, click here. For a New York Times' story about the discovery and its potential impact, click here.